Navigation Links
ArunA Biomedical Names Harold Ingalls to its Board of Directors

ATHENS, Ga., Sept. 9 /PRNewswire/ -- ArunA Biomedical, Inc., the first company to commercialize human embryonic stem cell derived products and services, announced today the appointment of former Serologicals Corporation CFO, Harold "Bud" Ingalls, to its Board of Directors.

(Logo: )

Mr. Ingalls brings over 40 years of financial leadership, including nearly 20 years of experience as a chief financial officer to ArunA's Board. Prior to his current role as CFO of Premier Exhibitions, Mr. Ingalls served as Vice President and Chief Financial Officer at CardioMEMS, where he played a key role in the organization's transformation. During his tenure at CardioMEMS, Mr. Ingalls led the completion of two private financing rounds totaling over $45 million with venture capitalists and strategic investors. From 2001 to 2006, he held the position of Vice President of Finance and Chief Financial Officer of Serologicals Corporation. Under Mr. Ingalls' leadership, Serologicals' enterprise value increased by nearly $1.0 billion, as the result of strong organic growth, successful acquisitions and stringent cost control. Prior to his work with Serologicals, Mr. Ingalls was employed as President and Chief Financial Officer of LaRoche Industries, Inc. Mr. Ingalls is a member of the American Institute of Certified Public Accountants and received a BBA degree in Accounting from the University of Wisconsin.

"We are pleased to welcome Bud to the ArunA Board. His domain knowledge and impressive combination of strategic and financial expertise in the life sciences industry will be a tremendous asset to ArunA Biomedical as we move forward in our next phase of growth," said ArunA President and CEO, William T. Sharp.

About ArunA Biomedical

Located in Athens, Georgia, ArunA Biomedical, Inc. is a privately held biotechnology corporation dedicated to the discovery, manufacturing and commercialization of emerging new technologies in human stem cell research for use in drug discovery and basic research. ArunA is the first company to commercialize products derived from human embryonic stem cells and sees its proprietary technology as a catalyst leading to the discovery of novel therapeutic compounds, tests for neurotoxicity and breakthroughs in understanding human development and diseases.

For more information, visit:

SOURCE ArunA Biomedical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Therapeutic DNA Vaccine Company Inovio Biomedical Reports Second Quarter 2008 Financial Results
2. Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardiovascular Tests
3. Creator of PubMed Central biomedical research database recognized for outstanding citizen service
4. Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion
5. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the Barbed OSStaple(TM) (BOSS) Nitinol Implant
6. Twenty of Americas Most Promising Scientists Selected as 2008 Pew Scholars in the Biomedical Sciences
7. The Foundation for Biomedical Research (FBR) Releases Feature DVD Majestic for World Premiere
8. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSAnchor(TM) Grip Nitinol Soft Tissue Anchor
9. Response Biomedical Corporation to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
10. The 2008 AMIA Spring Congress to Showcase Best Practices and Innovations in Biomedical and Health Informatics Research and Education
11. Marc Feldmann and Sir Ravinder Maini win Dr. Paul Janssen Award for Biomedical Research
Post Your Comments:
(Date:11/26/2015)... Viejo, CA (PRWEB) , ... November 26, 2015 ... ... users a new set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This ... style options. These classically-influenced trailer titles work with any font, giving users limitless ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor ... application server to improve system efficiency and reliability. , The new Q-Suite 6 platform ... standards, the system avoids locking itself into a specific piece of software for many ...
(Date:11/25/2015)... ... 2015 , ... As part of a global movement to ... together who want to combine talents and resources to help create sustainable communities ... The non-profit launched its first major fundraiser on November 6, 2015 at Bent ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in the traditional and ... of traditional and far-infrared saunas. , For traditional saunas, Finnleo is offering ... Finnish sauna wood, and Finnleo uses only European Grade A Nordic White Spruce from ...
(Date:11/25/2015)... ... November 25, 2015 , ... TyloHelo Inc , ... accessories. , Sauna accessories help improve the bather experience in the sauna, and ... styles for the purist looking for simplicity in design to accessories that encourage ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... "Radioimmunoassay Market by Type (Reagents & ... Academics, Clinical Diagnostic Labs), Application (Research, Clinical ... 2020" report to their offering. ... addition of the "Radioimmunoassay Market by ...
(Date:11/25/2015)... global healthcare industry is expected to grow at a rate ... has the highest projected growth at 12.7%, and ... is second with growth projected at 11.5%. ... 2013-2014, total government funded healthcare was nearly 68%. Federal government ... 2013-2014. In real terms, out of pocket expenditure increased by ...
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
Breaking Medicine Technology: